Denali Therapeutics | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (14)

View All

Latest Posts

About This Stock More About This Stock
Inhibikase Therapeutics: Targeted Therapies That Can Improve Quality Of Life
Article By: Ari Zoldan
Thursday, June 17, 2021 12:10 PM EDT
If the company gets the approval for IkT-148009, which is the company’s lead small drug candidate, and any progress is seen in other drug candidates, the shareholder value creation will be significantly greater than the projection mentioned above.
In this article: IKT Also: ABV, AZN, BIIB, DNLI
Read
Tuesday Talk: Action!
Article By: TalkMarkets DailyTalk
Tuesday, June 15, 2021 7:53 AM EDT
U.S. stock markets started the week in continued action mode. The S&P 500 closed at 4,255, up nearly 8 points, the Dow closed at 34,394, down 85 points and the Nasdaq Composite closed at 14,174, up nearly 105 points.
In this article: TAN Also: JPM, NEM, SCCO, XOM, IBB, AAPL, BIIB, SLV, XBI, VIX, PYPL, DNLI, SAVA
Read
Biotechs Ready To Roar
Article By: Tarun Chandra, CFA
Sunday, June 13, 2021 11:15 AM EDT
The recent FDA decision will reverberate across the industry and the healthcare sector for many reasons.
In this article: BIIB Also: LLY, IBB, XBI, XLV, SUPN, ITCI, BHVN, DNLI, SAVA, KRTX, ARVN, ANVS, INMB, AVXL, PRTA
Read
Chart: The 20 Top Stocks Of 2020 By Price Return
Article By: Jeff Desjardins
Monday, February 15, 2021 5:25 AM EDT
In the whirlwind of the pandemic, most businesses experienced chaos. From shuttered physical stores to the rapid rise of online activity, only a select few companies successfully weathered the storm.
In this article: TSLA, MRNA, ENPH, ZM, FVRR, PTON, TWST, CVAC, RUN, SE, BEAM, PDD, DNLI, SI, SDGR, FATE, BILI, NET
Read
The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs, And Conference Presentations In The Spotlight
Article By: Benzinga
Sunday, February 7, 2021 5:00 PM EDT
Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A activity, IPO news flow, and follow-on offerings all served to lift stocks higher.
In this article: JAZZ, NVAX, REGN, GWPH, ABEO, RGNX, DNLI, TAK, EQ, ORTX
Read
All Posts

Latest Tweets for $DNLI

No tweets yet!

PARTNER HEADLINES